These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 3480792)
41. Effects of enoxacin on renal and metabolic clearance of theophylline in rats. Nadai M; Hasegawa T; Kuzuya T; Muraoka I; Takagi K; Yoshizumi H Antimicrob Agents Chemother; 1990 Sep; 34(9):1739-43. PubMed ID: 2285287 [TBL] [Abstract][Full Text] [Related]
42. Influence of a newly developed quinolone, T-3761, on pharmacokinetics of theophylline in rats. Hasegawa T; Nadai M; Haghgoo S; Yamaki K; Takagi K; Nabeshima T Antimicrob Agents Chemother; 1995 Sep; 39(9):2138-40. PubMed ID: 8540732 [TBL] [Abstract][Full Text] [Related]
43. Relation between plasma and saliva concentrations of enoxacin, ciprofloxacin, and theophylline. Zhai S; Wei X; Parker BM; Kunze KL; Vestal RE Ther Drug Monit; 1996 Dec; 18(6):666-71. PubMed ID: 8946663 [TBL] [Abstract][Full Text] [Related]
44. Elimination of plasmids by enoxacin and ofloxacin at near inhibitory concentrations. Weisser J; Wiedemann B J Antimicrob Chemother; 1986 Nov; 18(5):575-83. PubMed ID: 3542924 [TBL] [Abstract][Full Text] [Related]
45. Effect of enoxacin on theophylline neurotoxicity. Hoffman A; Levy G Life Sci; 1989; 44(23):1803-6. PubMed ID: 2786601 [TBL] [Abstract][Full Text] [Related]
46. [The effect of new quinolone antimicrobial agents and macrolide antibiotics on the clearance of theophylline]. Honma M Nihon Rinsho; 1996 Nov; 54(11):3125-9. PubMed ID: 8950966 [TBL] [Abstract][Full Text] [Related]
47. Effect of fluconazole on theophylline disposition in humans. Konishi H; Morita K; Yamaji A Eur J Clin Pharmacol; 1994; 46(4):309-12. PubMed ID: 7957514 [TBL] [Abstract][Full Text] [Related]
48. Effect of traditional Chinese herbal medicines on the pharmacokinetics of western drugs in Sprague-Dawley rats of different ages (II): Aminophylline-huan shao tan and aminophylline-pu chung yi chi tang. Lin SY; Hou SJ; Perng RI; Chen SM; Young TK Mech Ageing Dev; 1992; 66(1):93-106. PubMed ID: 1340518 [TBL] [Abstract][Full Text] [Related]
49. Alteration of the pharmacokinetics of theophylline by rutaecarpine, an alkaloid of the medicinal herb Evodia rutaecarpa, in rats. Ueng YF; Tsai TH; Don MJ; Chen RM; Chen TL J Pharm Pharmacol; 2005 Feb; 57(2):227-32. PubMed ID: 15720787 [TBL] [Abstract][Full Text] [Related]
50. [In vitro activity of new quinolones against Mycoplasma pathogenic to humans]. Renaudin H; Quentin C; de Barbeyrac B; Bebear C Pathol Biol (Paris); 1988 May; 36(5):496-9. PubMed ID: 3136430 [TBL] [Abstract][Full Text] [Related]
51. The effect of low-dose cimetidine (200 mg twice daily) on the pharmacokinetics of theophylline. Nix DE; Di Cicco RA; Miller AK; Boyle DA; Boike SC; Zariffa N; Jorkasky DK; Schentag JJ J Clin Pharmacol; 1999 Aug; 39(8):855-65. PubMed ID: 10434239 [TBL] [Abstract][Full Text] [Related]
52. The clinical pharmacokinetics of levofloxacin. Fish DN; Chow AT Clin Pharmacokinet; 1997 Feb; 32(2):101-19. PubMed ID: 9068926 [TBL] [Abstract][Full Text] [Related]
53. Pharmacokinetic interactions between theophylline and other medication (Part I). Upton RA Clin Pharmacokinet; 1991 Jan; 20(1):66-80. PubMed ID: 1674242 [TBL] [Abstract][Full Text] [Related]
54. Pharmacokinetic changes of unbound theophylline are due to plasma protein binding displacement and CYP1A2 activity inhibition by baicalin in rats. Gao N; Fang Y; Qi B; Jia LJ; Jin H; Qiao HL J Ethnopharmacol; 2013 Nov; 150(2):477-84. PubMed ID: 24076258 [TBL] [Abstract][Full Text] [Related]
55. Selective in-vitro inhibition of hepatic oxidative metabolism by quinolones: 7-ethoxyresorufin and caffeine as model substrates. Valero F; de la Torre R; Segura J J Pharm Pharmacol; 1991 Jan; 43(1):17-21. PubMed ID: 1676053 [TBL] [Abstract][Full Text] [Related]
56. [Sensitivity of obligate anaerobes to ofloxacin, pefloxacin, enoxacin and norfloxacin]. Dubreuil L; Devos J; Romond C; Bryskier A Pathol Biol (Paris); 1985 May; 33(5):421-5. PubMed ID: 3162143 [TBL] [Abstract][Full Text] [Related]
57. The theophylline-enoxacin interaction: I. Effect of enoxacin dose size on theophylline disposition. Rogge MC; Solomon WR; Sedman AJ; Welling PG; Toothaker RD; Wagner JG Clin Pharmacol Ther; 1988 Nov; 44(5):579-87. PubMed ID: 3180639 [TBL] [Abstract][Full Text] [Related]
58. Pharmacokinetic drug interactions with theophylline. Jonkman JH; Upton RA Clin Pharmacokinet; 1984; 9(4):309-34. PubMed ID: 6147220 [TBL] [Abstract][Full Text] [Related]
59. Astragaloside IV inhibited the activity of CYP1A2 in liver microsomes and influenced theophylline pharmacokinetics in rats. Zhang YH; Zhang YJ; Guo YL; Li WJ; Yu C J Pharm Pharmacol; 2013 Jan; 65(1):149-55. PubMed ID: 23215698 [TBL] [Abstract][Full Text] [Related]
60. Effect of trovafloxacin, a new fluoroquinolone antibiotic, on the steady-state pharmacokinetics of theophylline in healthy volunteers. Vincent J; Teng R; Dogolo LC; Willavize SA; Friedman HL J Antimicrob Chemother; 1997 Jun; 39 Suppl B():81-6. PubMed ID: 9222075 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]